NDT MEDIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NDT MEDIC
Largest movements
- Tangible fixed assets +€16,757
new in 2025: €16,757
- Cash +€13,713
up €13,713 (+26.2%), from €52,292 to €66,005
mainly Net result for the year (+€76,241) and Other debts (+€24,635)
- Deferred charges and accrued income +€12,899
up €12,899 (+546%), from €2,363 to €15,262
- Other debts +€24,635
up €24,635 (+89.9%), from €27,407 to €52,041
- Profit (loss) carried forward +€13,741
new in 2025: €13,741
- Tax, wage and social debts +€4,837
up €4,837 (+55.7%), from €8,687 to €13,524
- Gross operating margin +€39,266
up €39,266 (+67.2%), from €58,449 to €97,716
- Taxes +€6,202
up €6,202 (+47.5%), from €13,065 to €19,267
- Depreciation -€5,495
down €5,495 (-75.7%), from €7,261 to €1,767
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €54,815 | €98,024 | +€43,209 | +78.8% |
| Fixed assets | 21/28 | - | €16,757 | +€16,757 | |
| Tangible fixed assets | 22/27 | - | €16,757 | +€16,757 | |
| Other tangible fixed assets | 26 | - | €16,757 | +€16,757 | |
| Current assets | 29/58 | €54,815 | €81,268 | +€26,453 | +48.3% |
| Amounts receivable within one year | 40/41 | €160 | - | -€160 | |
| Trade receivables | 40 | €160 | - | -€160 | |
| Cash at bank and in hand | 54/58 | €52,292 | €66,005 | +€13,713 | +26.2% |
| Deferred charges and accrued income | 490/1 | €2,363 | €15,262 | +€12,899 | +546% |
| Total equity and liabilities | 10/49 | €54,815 | €98,024 | +€43,209 | +78.8% |
| Equity | 10/15 | €18,600 | €32,341 | +€13,741 | +73.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €13,741 | +€13,741 | |
| Amounts payable | 17/49 | €36,215 | €65,684 | +€29,469 | +81.4% |
| Amounts payable within one year | 42/48 | €36,215 | €65,684 | +€29,469 | +81.4% |
| Trade debts | 44 | €121 | €119 | -€2 | -1.9% |
| Suppliers | 440/4 | €121 | €119 | -€2 | -1.9% |
| Taxes, remuneration and social security | 45 | €8,687 | €13,524 | +€4,837 | +55.7% |
| Taxes | 450/3 | €8,687 | €13,524 | +€4,837 | +55.7% |
| Other amounts payable | 47/48 | €27,407 | €52,041 | +€24,635 | +89.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,261 | €1,767 | -€5,495 | -75.7% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €58,449 | €97,716 | +€39,266 | +67.2% |
| Operating profit (loss) | 9901 | €50,804 | €95,562 | +€44,758 | +88.1% |
| Financial income | 75/76B | €36 | - | -€36 | |
| Recurring financial income | 75 | €36 | - | -€36 | |
| Financial charges | 65/66B | €293 | €54 | -€239 | -81.5% |
| Recurring financial charges | 65 | €293 | €54 | -€239 | -81.5% |
| Profit (loss) for the period before taxes | 9903 | €50,547 | €95,508 | +€44,961 | +88.9% |
| Income taxes | 67/77 | €13,065 | €19,267 | +€6,202 | +47.5% |
| Profit (loss) for the period | 9904 | €37,481 | €76,241 | +€38,759 | +103% |
| Profit (loss) for the period to be appropriated | 9905 | €37,481 | €76,241 | +€38,759 | +103% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.